IMC Chicago’s Genmab GMAB Stock Holding History

IMC Chicago’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$755K	Buy	+27,500	New	+$731K	﹤0.01%	4183

Other funds holding GMAB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

EGA

Eagle Global Advisors Houston, Texas $3.02B AUM 34.37% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

LWAM

Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 35.19% 1-Year Est. Return

IMC Chicago's GMAB Position: Q2 2026 in Review

IMC Chicago opened a new position in Genmab (GMAB) in Q2 2026: 71,596 shares worth $1.97M. The stake represents ﹤0.01% of the portfolio and ranks #3053 among its holdings. This is a return to the name: IMC Chicago previously reported a position in GMAB as recently as Q4 2025.

IMC Chicago first reported a position in GMAB in Q3 2025 and has held it in 3 quarters since. 135 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

IMC Chicago held 71,596 shares of Genmab worth $1.97M as of Q2 2026.
Genmab was a new IMC Chicago position in Q2 2026.
Genmab made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #3053 holding.
IMC Chicago first reported a position in Genmab in Q3 2025 and has held it in 3 quarters since.
135 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.